Trial Profile
In-vivo Efficacy and Safety of Artemether/Lumefantrine Vs Dihydroartemisinin-piperaquine for Treatment of Uncomplicated Malaria and Assessment of Parasite Genetic Factors Associated With Parasite Clearance or Treatment Failure
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 29 Dec 2017
Price :
$35
*
At a glance
- Drugs Dihydroartemisinin/piperaquine (Primary) ; Artemether/lumefantrine
- Indications Malaria
- Focus Therapeutic Use
- 22 Dec 2017 Status changed from active, no longer recruiting to completed.
- 02 Nov 2015 New trial record